Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350

Daruka Mahadevan, Joseph M. Unger, Catherine M. Spier, Daniel O. Persky, Fay Young, Michael Leblanc, Richard I. Fisher, Thomas P. Miller

Research output: Contribution to journalArticle

74 Scopus citations

Fingerprint Dive into the research topics of 'Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350'. Together they form a unique fingerprint.

Medicine & Life Sciences